News Releases

Toronto, Canada, April 21, 2016 – FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Vevo® MD, the world’s first Ultra High Frequency (UHF) clinical ultrasound system. With multiple successes in preclinical research over the last decade, theVevo® MD is FUJIFILM VisualSonics’ first foray into the clinical market.
Toronto, Canada, January 11, 2016 - FUJIFILM VisualSonics Inc., a world leader in ultra high frequency  ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., announces CE mark for the Vevo® MD, the world’s first Ultra High Frequency (UHF) clinical ultrasound system. With multiple successes in preclinical research over the last decade, today marks a major milestone for FUJIFILM VisualSonics as it expands into the clinical market.
Toronto, Canada, September 17, 2014 - FUJIFILM VisualSonics will unveil the world’s first one-touch pre-clinical imaging platform, the Vevo® 3100 on September 17 -20 at the World Molecular Imaging Congress Annual Meeting in Seoul, Korea.
TORONTO, Canada –October 10, 2013 - Using high-frequency ultrasound and special cardiac-assessment software by FUJIFILM VisualSonics, Inc., researchers have been able to implant engineered stem cells into the damaged heart tissue of mice and, over time, observe the regeneration of healthy cardiac rhythms.
TORONTO, Canada – April 14, 2011 - VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., announced today that its VevoStrain™ technology has been featured on the cover of the April 15th, 2011 issue of Circulation Research, Journal of the American Heart Association.
TORONTO, Canada – April 4, 2011 – VisualSonics Inc., a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., (Nasdaq:Sono), is demonstrating the recently announced Vevo® LAZR Photoacoustics Imaging system at the American Association of Cancer Research’s annual conference (April 2-6, 2011, Orlando, FL).
BOTHELL, WA- June 30, 2010 – SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that on June 30, 2010, it completed its acquisition of privately held VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9 million net of cash and debt.
BOTHELL, WA- May 27, 2010 – SonoSite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology.
TORONTO, Canada - April 14, 2010 – VisualSonics Inc and Bracco Group today announced the launch of VevoCQ™ Advanced Quantification Software Tools for the Vevo® 2100 linear array based high-frequency ultrasound imaging system.
TORONTO, Canada – October 16, 2009 – TORONTO, Canada – October 16, 2009 - VisualSonics Inc., a leader in real time, in vivo, high-resolution micro imaging systems, today introduced the NeuroPak™ Deep Brain Imaging System. NeuroPak™ is a novel technology that provides pre-clinical neurology researchers with the capability to image biological and cellular processes in the brains of conscious animals. Read more.
Share

Request a Quote or Demo

Request Now